Patients who show evidence of endoscopic recurrence are then offered treatment
Multi-pathway engagement (ECM, oxidative stress, inflammatory tone)
Together, they bring real-world medical experience beyond the hospital and into the community, delivering transparent, medically responsible in-home IV care designed to meaningfully support each individual they serve
At 2.5mg/ml, that same one-unit error equals only 0.025mg
Mechanism of action Nitric oxide pathway upregulation (eNOS), VEGF/VEGFR2-driven angiogenesis, FAK-paxillin cell migration, Egr-1 collagen synthesis, NF-B anti-inflammatory signaling, growth hormone receptor upregulation Typical research dosage Beginner protocol mg / Woche Advanced protocol 250-500 mcg once or twice daily, subcutaneously Note: The dosages listed correspond to typical ranges from published research literature